Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Revenue Growth (3y) (2012 - 2026)

Analysis

Revvity (RVTY) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 3.92%
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 1.95%
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 3.95%
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -0.48%
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 0.96%
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 2.15%
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -1.50%
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 8.65%
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 0.95%
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 7.13%
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 0.96%
Apr 5, 2026 1.76%
Dec 28, 2025 1.37%
Sep 28, 2025 -0.61%
Jun 29, 2025 -7.01%
Mar 30, 2025 -11.63%
Dec 29, 2024 -10.81%
Sep 29, 2024 -7.39%
Jun 30, 2024 -8.76%
Mar 31, 2024 -14.17%
Oct 1, 2023 -11.39%
Jul 2, 2023 -4.41%
Apr 2, 2023 1.14%
Jan 1, 2023 -2.73%
Oct 2, 2022 0.23%
Jul 3, 2022 7.42%
Apr 3, 2022 14.08%
Jan 2, 2022 10.77%
Oct 3, 2021 8.50%
Jul 4, 2021 8.99%